<div id="readability-page-1"><div><div><p>Merck and Siemens have signed a new partnership to accelerate AI for drug development</p><p>Projects include the development of AI-based tools and digital interfaces to simplify complex scientific processes</p><p>The agreement covers the provision of integrated software solutions, systems, and consumables that leverage automation, data, and AI to connect discovery, development, and commercialization of drugs.</p><p>Through this collaboration with Siemens, we are opening up new possibilities for scientists to move more quickly from an idea in the lab to a treatment for patients, Marck said. </p><p>We are partnering with Merck to provide scientists around the world with the tools they need to accelerate the development of vital medicines, Siemens said.</p></div></div></div>

默克

西门子公司

西门子(ADR)

<p>西门子和默克已建立合作关系，以增强药物开发中的人工智能。此次合作旨在创建基于人工智能的工具和数字接口，以简化科学流程。该协议包括集成软件解决方案和系统，利用自动化和数据连接药物发现、开发和商业化。预计这一合作将帮助科学家加快从实验室创意到患者治疗的转变</p>

西门子与默克合作，加速药物的发现和开发